Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Tom Drolet who wrote (3254)	2/3/2000 9:25:00 AM
From: Tom Drolet	Read Replies (1) \| Respond to of 14101

Folks: Looks like our favourite does want to move this am-- showing $4.90 at market minus 10 min. Tom D.

To: Tom Drolet who wrote (3254)	2/3/2000 1:41:00 PM
From: Mark Bartlett	Read Replies (1) \| Respond to of 14101

Tom OT T.CUR Looks interesting. If the sensitivity and specificity are as good as a biopsy, this will save the system a lot of $$.. Also - there are a lot of us out there that would much prefer this to the present invasive approach. The fact that this test appears to be able to discern between cancer and BPH is a real plus. I wonder what the competition is like in this area? The market is certainly there -- and will be growing considerably in the next 20 years. I am going to order an investors pack. Looks like our favourite Biotech is finally getting a little well deserved recognition .... go DMX!! MB